Evidence map›Paper›PMID 42811582›Full record

ReviewZhonghua shao shang yu chuang mian xiu fu za zhi2026

[Research progress on the application of stem cells and their derivatives in chronic wound repair].

R X Wu, J M Shen, F Y Duan, B Chen, Q H Sheng, L Z Yang, X K Li, Q Xu, Z G Wang

Abstract readReviewEnglish Abstract
In one paragraph

Review in Zhonghua shao shang yu chuang mian xiu fu za zhi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

R X WuDepartment of Wound Repair, Center for Wound Repair and Regenerative Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
J M ShenDepartment of Wound Repair, Center for Wound Repair and Regenerative Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China.
F Y DuanSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
B ChenSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
Q H ShengSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
L Z YangSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
X K LiSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
Q XuSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
Z G WangDepartment of Wound Repair, Center for Wound Repair and Regenerative Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.

Funding

The Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang 2023R01002Youth Fund of the National Natural Science Foundation of China 82503047
6 · The paper itself

Abstract

Chronic wounds are characterised by factors including persistent inflammation, impaired angiogenesis, cellular dysfunction, and infection, which hinder the normal healing process, thereby not only severely compromising patients' quality of life but also imposing a substantial socioeconomic burden. For this type of wounds, conventional treatments are often limited in efficacy and associated with issues such as prolonged treatment duration and high costs. Recently, research on stem cells and their derivatives in the field of wound repair has been developing rapidly. Stem cells accelerate wound healing primarily through potent paracrine effects and immunomodulatory functions, complemented by multilineage differentiation potential, which synergistically modulate inflammation, promote angiogenesis, and facilitate collagen remodeling. Furthermore, engineering strategies including genetic modification, three-dimensional culture, and biomaterial-based delivery have significantly improved stem cell bioactivity and adaptability to the wound microenvironment. Concurrently, stem cell derivatives, particularly exosomes, have attracted increasing attention as a next-generation "cell-free" therapeutic strategy owing to their low immunogenicity, high stability, abundance of bioactive factors, and capacity for bioengineering modification. It offers a new approach to the precise regeneration of complex wounds. This review aims to review the pathological mechanisms underlying chronic wounds, research progress on therapeutic application of stem cells and their derivatives, engineering strategies, and translational challenges in clinical application, providing a reference for future research in the field.

Indexed as

Stem CellsStem Cell TransplantationWound HealingChronic DiseaseHumansTissue Engineering

Identifiers

PMID42811582
PMCPMC13654639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.